Xiamen Amoytop Biotech Co.,Ltd.’s Net Profit Rose 84.1% in First Three Quarters of 2023

Xiamen Amoytop Biotech Co.,Ltd. (厦门特宝生物工程股份有限公司) (688278.SH) reported a net profit of 368.9 million yuan in the first three quarters of 2023, up 84.1% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, up 27.7% year-on-year.

At the end of the reporting period, it had 2.1 billion yuan in total assets and 447.4 million yuan in total liabilities, with a liability-to-asset ratio of 20.9%.